Business
Regeneron Pharmaceuticals, Inc. (REGN) Is Worth A Look Now, Despite -9.38% Loss From High
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) concluded the trading at $904.70 on Friday, April 12 with a fall of -1.70% from its closing price on previous day.